Simple research view

BMY · Bristol-Myers Squibb Company

$62.56 latest stored close

Detected setup Trend Only

Watch · Quality 78/100

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$BMY

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $128B.

Strong Buy · 91 Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 2 Data 50m ago

$62.56 latest close

← Back Join to Watchlist $BMY Share card

Council read · 6 methods

Watch — evidence is building

0 buyable · 4 watch · 2 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart

Earnings-risk mode

Pre-earnings setup

Thursday, July 30, 2026 Time not confirmed No sourced report session or clock time

Ordinary position sizing suppressed. Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.

Deterministic evidence

BMY+0.76%

Sector proxy · XLV+0.51%

Broad market · SPY+0.02%

Same completed session window ending 2026-07-27. BMY was +0.25 points vs XLV. +0.74 points vs SPY.

CatalystUnavailable Stock reactionPositive Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.

Price $62.56 Jul 27 close

52W High $63.44 -1.4%

52W Low $42.52

Wks Since High 0w

Tight Wks 1

Base B2

SMA 50 $57.57

SMA 200 $55.17

Avg Vol 11,931,550

RS Rank 64

RS vs High -10.4%

RS Slope +7.1% ▲

Grp Rank #17/66

ADR% 2.5%

ATR(14) $1.51 (2.4%)

Rel Vol (today) 0.86×

Vol Pace N/A

U/D Vol 1.19

A/D Days 12A / 10D

A/D Rating B

VDU Bars 0/10 d

Power Trend 9d

Earnings 2d

$42.52

$63.44 96%

BMY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for BMY.

Create Free Account

Setup Quality B 4/7 signals

Score trend

✓ Stage 2 · Advancing ✓ Power Trend 9d ✗ RS New High ✓ Trend 6/8 ✗ No Pattern ✓ Gatekeeper Base #2 (B)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$BMY · $62.56 · as of 2026-07-27 · multi-factor read

/ 100

Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend

Weekly ▲ Recovering / early uptrend

Monthly ▬ Sideways / consolidating

Moving Averages

50-day$57.57 ↑

100-day$58.15 ↑

200-day$55.17 ↑

Bullish (50 > 200)

RSI (14)

Reading65.2 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish

Histogram+0.383

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width96% · 12.7%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol1.19 · Neutral

Rel volume0.86×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $62.89swing level

Price · $62.56now

S · $59.23swing level

S · $56.92swing level

S · $55.40swing level

Fibonacci · Uptrend swing

23.6%$61.08

38.2%$59.62

50.0%$58.44

61.8%$57.26

78.6%$55.58

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for BMY — plus the full 495-symbol scanner and Ask-the-Legends chat.

🔒 Start your 7-day free trial →

Daily uptrendWeekly uptrendAbove 200-day MA50/200 bullish

Want this read in a legend's voice? 💬 Ask a Legend about BMY

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 4 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Avoid

Minervini C

Trend-template read: fails 50-day MA > 150-day MA AND 200-day MA.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $62.56, MA150 $57.81, MA200 $55.17

1.2 150-day MA > 200-day MAMA150 $57.81 vs MA200 $55.17

Failing evidence

1.4 50-day MA > 150-day MA AND 200-day MAMA50 $57.57, MA150 $57.81, MA200 $55.17

1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 63

7/10 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).

Passing evidence

C: Quarterly EPS acceleration ≥ 25%+25.4% QoQ

A: Annual earnings & revenue qualityRev -0.2% | ROE 41.6%

Failing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 63

S: Volume ≥ 40% above average on breakoutVolume ratio 0.86x

4/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $62.56 vs MA200 $55.17

Failing evidence

Stage 1→2 breakout on expanding volume0.86x on the fresh 30-week MA breakout — needs ≥1.4x to confirm

Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base

5/7 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$62.56

Distance from 52-week high1.4% below high

Failing evidence

Relative strengthRS 63

Volume vs average0.86x

3/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$62.56

Distance from 52-week high1.4% below high

Failing evidence

Relative strengthRS 63

Volume vs average0.86x

3/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$62.56

Distance from 52-week high1.4% below high

Failing evidence

Relative strengthRS 63

Volume vs average0.86x

3/6 checks

Method → Playbook → Ask →

Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

🕯 Latest candle: Shooting Star — Long upper shadow with a small body near the low — sellers rejected higher prices. A caution flag when price is extended above a pivot.

Unlock Follow-Through Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +1 B

Minervini · Grade Card

Fundamentals & leadership quality — Minervini SEPA criteria · 5/7 met

B 5/7 SEPA

Separate score from the 8-point Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✓ EPS acceleration ≥25% QoQ +25%

✗ Revenue growth ≥20% YoY -0%

✓ Gross margin ≥30% 54%

✓ ROE ≥17% 42%

✗ RS rating ≥80 (leadership) 63

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -1.4%

Method Playbook

📋 Trade it like O'Neil EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.

Pivot

Pro level

Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Forming Patterns (predictive — not confirmed)

Cup & Handle bullish forming

75% built

Right side of cup nearly rebuilt (97% recovered). Watch for a shallow handle to form near ~62.89 before a breakout attempt — buying here, ahead of the handle, is premature.

Pivot Watch 0.52% away

Tightness / volume Tightening · No VDU

Recent-pace band 1–2 sessions

Confirms above 62.89

Invalidates at 58.16

Rim 62.89

Cup Low 53.44

Pivot 62.89

Mid Cup 58.16

Cup depth 15%, recovery 97%, handle=not yet

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

Trend Only

77.8 score

RS Score 63

Trend 6/8 ✓

Why This Setup?

Trend Only

Gatekeeper 6/8 | Moderate trend (6/8) | Good RS (63) | Power Trend | Stage 2

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met

In a confirmed uptrend Stage 2 · Trend 6/8
Risk is defined No stop — undefined risk
Asymmetric reward No target set
Not chasing (in range) Pivot distance unknown
Volume confirms 0.9× average — light
Clear of earnings in 2 days — event risk
A relative-strength leader RS 64 — middling

Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $62.56 vs SMA150 $57.81 / SMA200 $55.17

SMA 150 above SMA 200 SMA150 $57.81 vs SMA200 $55.17

SMA 200 trending up Slope +1.37 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $57.57

Price above SMA 50 $62.56 vs SMA50 $57.57

30%+ above 52W low +47.1% from $42.52

Within 25% of 52W high -1.4% from $63.44

RS score above 70 RS 63

Fundamentals

52W Range

96%

Mkt Cap SEC

127.8B

EPS QoQ

+25%

Rev YoY

-0%

ROE

42%

Gross Margin

54%

D/E

2.44

EPS TTM

$3.46

P/E TTM

18.1x

Float

2.0B

Insider

No Buy

Company

Legend AI snapshot

Bristol-Myers Squibb Company

BMY · NYSE · Health Technology · Pharmaceuticals: Major

$62.56latest close $127.8Bmarket cap 64RS rank 78setup score

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

7/8

W. RS

W. Support

$53.44

W. Resist

$62.89

Weekly Structure

Trend Neutral

Tight Weeks 1

Confirmation Neutral

Scan History

20× streak

Jul 28

Trend Only ✓ Gate

Jul 28

Trend Only ✓ Gate

Jul 28

Trend Only ✓ Gate

Jul 27

Darvas Box ✓ Gate

81 0.0%

Jul 27

Darvas Box ✓ Gate

81 0.0%

Jul 24

Trend Only ✓ Gate

75 +0.8%

Get the full picture on BMY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial